Thiazolidinediones (TZDs) are oral medications that are used to treat T2DM by acting as agonists for the nuclear transcription factor called peroxisome proliferator-activated receptor-gamma (PPAR-γ). The gene discussed is PPARG; the disease is type 2 diabetes mellitus.